Jasmini Alagaratnam
- Infectious Diseases top 10%
- Virology top 5%
- Emergency Medicine top 10%
- Epidemiology
- Neurology
- Co-authors
- Alan WinstonJonathan UnderwoodSarah FidlerHenrik ZetterbergDavide De FrancescoPaul EdisonPaola CinqueMarta Boffito
- Topics
- HIV/AIDS Research and Interventions (11 papers)HIV Research and Treatment (10 papers)HIV-related health complications and treatments (9 papers)
- Partner nations
- United KingdomItalySweden
In The Last Decade
Jasmini Alagaratnam
20 papers receiving 268 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Infectious Diseases 119
- Virology 89
- Emergency Medicine 85
- Epidemiology 49
- Neurology 33
Countries citing papers authored by Jasmini Alagaratnam
This map shows the geographic impact of Jasmini Alagaratnam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmini Alagaratnam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmini Alagaratnam more than expected).
Fields of papers citing papers by Jasmini Alagaratnam
This network shows the impact of papers produced by Jasmini Alagaratnam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmini Alagaratnam. The network helps show where Jasmini Alagaratnam may publish in the future.
Co-authorship network of co-authors of Jasmini Alagaratnam
This figure shows the co-authorship network connecting the top 25 collaborators of Jasmini Alagaratnam. A scholar is included among the top collaborators of Jasmini Alagaratnam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmini Alagaratnam. Jasmini Alagaratnam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | Major revision version 12.0 of the European | 75 |
| 9 | 13 | |
| 10 | 14 | |
| 11 | 74 | |
| 12 | 15 | |
| 13 | 6 | |
| 14 | 0 | |
| 15 | 8 | |
| 16 | 14 | |
| 17 | 11 | |
| 18 | 1 | |
| 19 | Tay-Sach disease with "cherry-red spot"--first reported case in Malaysia. | 2 |
| 20 | Esomeprazole does not improve asthma control | 1 |
About Jasmini Alagaratnam
Jasmini Alagaratnam is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 23 papers that have together received 270 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (11 papers), HIV Research and Treatment (10 papers) and HIV-related health complications and treatments (9 papers). The work is most often cited by research in Virology (89 citations), Emergency Medicine (85 citations) and Infectious Diseases (119 citations). Jasmini Alagaratnam has collaborated with scholars based in United Kingdom, Italy and Sweden. Frequent co-authors include Alan Winston, Jonathan Underwood, Sarah Fidler, Henrik Zetterberg, Davide De Francesco, Paul Edison, Paola Cinque, Marta Boffito, Christoph Boesecke and Hylke Waalewijn. Their work appears in journals such as The Journal of Infectious Diseases, Thorax and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.